Phase II study of TKIs as neo(adjuvant) therapy in stage II-III resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 alterations Meeting Abstract
| Authors: | Lee, J.; Wistuba, I.; Ngiam, C.; Yu, W.; Schulze, K.; Rocha, M.; Bara, I.; Carbone, D.; Johnson, B.; Kwiatkowski, D.; Center, M. S. K.; Chaft, J. |
| Abstract Title: | Phase II study of TKIs as neo(adjuvant) therapy in stage II-III resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 alterations |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | neoadjuvant; induction; adjuvant |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S259 |
| End Page: | S260 |
| Language: | English |
| ACCESSION: | WOS:000631349600364 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.377 |
| Notes: | Meeting Abstract: P03.04 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
